Guidesto Peptides

GLP-1 Peptides (Semaglutide)

Wellness

Also known as: Semaglutide, Tirzepatide, Liraglutide, GLP-1 Receptor Agonists

Well-Studied

What is GLP-1 Peptides (Semaglutide)?

Prescription-only weight management peptides including Ozempic, Wegovy, and Mounjaro. The most clinically proven class of peptides for obesity and type 2 diabetes management. PRESCRIPTION ONLY.

How it works

Mimic the GLP-1 (glucagon-like peptide-1) hormone to activate GLP-1 receptors, suppressing appetite via hypothalamic signaling, slowing gastric emptying to increase satiety, and improving insulin sensitivity and glucose regulation.

What marketers claim

  • ▸effortless weight loss with no lifestyle changes needed
  • ▸cures obesity permanently
  • ▸no significant side effects
  • ▸works the same for everyone

What evidence supports

  • ✓large-scale clinical trials demonstrate 15–20% body weight reduction
  • ✓FDA-approved for obesity (BMI 30+) and type 2 diabetes management
  • ✓cardiovascular outcome benefits documented in major trials
  • ✓most clinically substantiated weight-loss intervention available

Best for

clinically obese patients under physician supervisiontype 2 diabetes management

Safety notes & concerns

  • ⚠prescription only — not available or appropriate without physician oversight
  • ⚠significant GI side effects common: nausea, vomiting, diarrhea, constipation
  • ⚠potential muscle mass loss without adequate protein intake and resistance training
  • ⚠weight typically returns if medication is stopped without lifestyle changes
  • ⚠cost is $1,000+ per month without insurance coverage
  • ⚠compounded versions may be unregulated and of unknown purity
  • ⚠rare but serious risk of pancreatitis

Pairs well with

structured resistance exercise programadequate protein intake (1.2–1.6g/kg)regular medical monitoring

Use caution with

personal or family history of medullary thyroid carcinomaMultiple Endocrine Neoplasia syndrome type 2 (MEN2)not for cosmetic weight loss without a clinical indication

Products containing GLP-1 Peptides (Semaglutide)

Novo Nordisk

Wegovy (Semaglutide 2.4mg)

Injectable

FDA-approved once-weekly injectable for chronic weight management; the most clinically proven peptide intervention for obesity with 15–17% average body weight reduction in STEP trials. PRESCRIPTION REQUIRED.

GLP-1 Peptides (Semaglutide)
$1,350.004 pens/month (2.4mg/0.5ml per dose)
★4.3

Eli Lilly

Mounjaro (Tirzepatide)

Injectable

Dual GIP/GLP-1 receptor agonist — the first of its class, approved for type 2 diabetes (Mounjaro) and obesity (Zepbound). SURMOUNT trials showed up to 22% average body weight reduction. PRESCRIPTION REQUIRED.

GLP-1 Peptides (Semaglutide)
$1,100.004 pens/month (various doses: 2.5–15mg/0.5ml)
★4.5

Last updated: 2025-03-01

Medical Disclaimer

The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.